![David Hallal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hallal
Directeur Général chez
SCHOLAR ROCK HOLDING CORPORATION
Fortune : 21 M $ au 31/05/2026
Profil
M. David L. Hallal est président-directeur général d'AlloVir, Inc. et président d'iTeos Therapeutics SA, président d'iTeos Therapeutics, Inc. et administrateur principal indépendant de Seer, Inc. (Californie), président-directeur général de ElevateBio LLC, président de Scholar Rock, Inc. et président de Scholar Rock Holding Corp. Il est membre du conseil d'administration de Seer, Inc. (Californie) et de Pharmaceutical Research & Manufacturers of America. Auparavant, M. Hallal a occupé les postes de directeur général et de directeur chez Alexion Pharmaceuticals, Inc, de vice-président des ventes chez (OSI) Eyetech, de chef des ventes chez Biogen Idec, Inc, de directeur des ventes d'oncologie du Sud-Est chez Amgen, Inc, et de directeur des ventes nationales chez Eyetech Pharmaceuticals, Inc. Il a obtenu son diplôme de premier cycle à l'université du New Hampshire.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 403 530 ( 0,35% ) | 20 M $ | 31/05/2026 | |
0,55% | 03/06/2026 | 130 554 ( 0,55% ) | 688 020 $ | 31/05/2026 |
Dernières actualités sur David Hallal
Postes actifs de David Hallal
| Sociétés | Poste | Début |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Général | 27/04/2025 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | - |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Président | 06/07/2017 |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Président | 27/06/2018 |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Fondateur | 01/12/2017 |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome editing and engineering services | Directeur/Membre du Conseil | - |
Anciens postes connus de David Hallal
| Sociétés | Poste | Fin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Président | 28/08/2025 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Général | 12/12/2016 |
(OSI) Eyetech
 (OSI) Eyetech Medical SpecialtiesHealth Technology Provides medical services | Sales & Marketing | 01/06/2006 |
| ░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Hallal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Seer, Inc. (California)
 Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
LifeEDIT Therapeutics, Inc.
LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome editing and engineering services | Commercial Services |
